FilingReader Intelligence
Yunnan Baiyao acquires Juyun Hall Pharmaceutical for 660m yuan
August 15, 2025 at 05:25 PM UTC•By FilingReader AI
Yunnan Baiyao will acquire 100% of Juyun Hall Pharmaceutical for 660 million yuan through a subsidiary.
Juyun Hall specializes in traditional Chinese medicine with a diverse product portfolio and was valued at 678.64 million yuan.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Announcement regarding the wholly-owned acquisition of Anguo City Juyantang Pharmaceutical Co., Ltd.August 15, 2025 at 08:00 AM UTC
Announcement regarding the proposed change of the company's audit firm for the 2025 financial year (including internal control audit)August 15, 2025 at 08:00 AM UTC
Tianxing Pingbao Zi [2025] No. 1013: Asset valuation report for the project on the value of all shareholder equities of Anguo Juyuetang Pharmaceutical Co., Ltd. related to the proposed equity acquisition by Yunnan Baiyao Group Chinese Medicine Resources Co., Ltd.August 15, 2025 at 08:00 AM UTC
SZSE:000538•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Yunnan Baiyao Group publishes news
Free account required • Unsubscribe anytime